structure of Spiro[3.5]non-7-en-6-one

Spiro[3.5]non-7-en-6-one

CAS No.: 221342-49-0
M. Wt: 136.19100
M. Fa: C9H12O
InChI Key: WBMWURFLKPUABN-UHFFFAOYSA-N

Names and Identifiers of Spiro[3.5]non-7-en-6-one

CAS Number

221342-49-0

IUPAC Name

spiro[3.5]non-6-en-8-one

InChI

InChI=1S/C9H12O/c10-8-3-1-4-9(7-8)5-2-6-9/h1,3H,2,4-7H2

InChIKey

WBMWURFLKPUABN-UHFFFAOYSA-N

Canonical SMILES

C1CC2(C1)CC=CC(=O)C2

Physical and chemical properties of Spiro[3.5]non-7-en-6-one

Exact Mass

136.08900

LogP

2.07580

Molecular Formula

C9H12O

Molecular Weight

136.19100

PSA

17.07000

Safety Information of Spiro[3.5]non-7-en-6-one

Pictograms

Signal Word

 Warning

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Applications of Spiro[3.5]non-7-en-6-one

Spiro[3.5]non-7-en-6-one has several applications across different fields:

  • Pharmaceuticals: Its derivatives are investigated for potential use as drugs due to their biological activity.
  • Chiral Auxiliaries: Used in asymmetric synthesis to produce enantiomerically enriched compounds.
  • Material Science: The unique structure may lend itself to applications in developing new materials with specific properties.

Interaction Studies of Spiro[3.5]non-7-en-6-one

Interaction studies involving spiro[3.5]non-7-en-6-one focus on its reactivity with various nucleophiles and electrophiles, providing insights into its behavior in biological systems and synthetic pathways. These studies are essential for understanding how modifications to the compound's structure can enhance or alter its biological activity.

Biological Activity of Spiro[3.5]non-7-en-6-one

Research has indicated that spiro[3.5]non-7-en-6-one and its derivatives exhibit various biological activities. Notably, they have been studied for their potential as antimicrobial agents, with some derivatives showing promising results in inhibiting bacterial growth. Additionally, certain spiro compounds have been explored for their roles as chiral auxiliaries in asymmetric synthesis, enhancing the efficiency of reactions in drug development.